eVisit
PrivateLast Round
Strategic
Jun 25, 2024
Total Funding Raised
$62M
Company Overview
eVisit is a healthcare technology company that offers a virtual care platform designed to enhance outcomes, revenue, and efficiencies for healthcare organizations by connecting physicians with patients and improving healthcare delivery.
Sector
Healthcare & Life Sciences
Verticals
Telemedicine, Patient Engagement, Vertical SaaS, Workflow Automation
Business Model
B2B
Customer Profile
Subscription SaaS, Services & Consulting
AI Layer
Application
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
eVisit Comparables
Compare eVisit with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| 98point6 Technologies | 82% | |
| VeeOne Health | 81% | |
| Andor Health | 80% | |
eVisit Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Strategic | Jun 25, 2024 | ||||
| Series B | Sep 21, 2021 | ||||
| Series A | Oct 20, 2020 | ||||
| Seed | Jun 1, 2017 | ||||
| Seed | Jul 28, 2015 |
eVisit Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| University Growth Fund | Series A |
| Goldman Sachs Asset Management Private Equity | Series B |
| Arizona Founders Fund | Seed |
| TVC Capital | Series A |
| Kickstart Fund | Seed, Series A |
| Goldman Sachs Asset Management | Series B |
| Kickstart | Seed, Series A |
Market signals
Structured signals derived from secondary market and firmographic data.
- Feb 5, 2025
Named a Best in KLAS winner for 2025 in virtual care.
- Feb 5, 2025
Named a Best in KLAS winner for 2025 in virtual care.
eVisit Filings
SEC and related filings with document metadata.
| Typed | Date | Amount Offered | Amount Sold | Filling | Pages | Download |
|---|---|---|---|---|---|---|
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Frequently Asked Questions
Common questions about eVisit's valuation, stock price, and market status.